LabCorp® announced that Covance Drug Development has relocated its clinical research unit in Dallas, TX, to a new, fit-for-purpose clinical research facility.
Designed to ensure patients and patients in clinical trials safely receive their proper medications, the regulation serves as a verification measure to enforce the European Union’s Falsified Medicine Directive.
Almac Group announced the successful completion of the Health Sciences Authority (HSA) inspection of its new Asia Pacific headquarters in Singapore.
This expansion will increase their global footprint and will allow them to provide a full range of services.
Quintiles and Quest Diagnostics announced the launch of Q2 Solutions, their new combined clinical trials laboratory services organization.